AJP - Endo AJP: Cell Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab (April 9, 2002). doi:10.1152/ajpendo.00329.2001
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
283/2/E346    most recent
00329.2001v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bajaj, M.
Right arrow Articles by DeFronzo, R. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Bajaj, M.
Right arrow Articles by DeFronzo, R. A.

Articles in PresS, published online ahead of print April 9, 2002
Am J Physiol Endocrinol Metab, 10.1152/ajpendo.00329.2001
Submitted on July 20, 2001
Accepted on April 8, 2002

Free Fatty Acid-Induced Peripheral Insulin Resistance Augments Splanchnic Glucose Uptake in Healthy Non-Diabetic Human Subjects

Mandeep Bajaj1*, Rachele Berria1, Thongchai Pratipanawatr1, Sangeeta Kashyap1, Wilailak Pratipanawatr1, Renata Belfort1, Kenneth Cusi1, Lawrence Mandarino1, and Ralph A. DeFronzo1

1 Diabetes Division, Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA

* To whom correspondence should be addressed. E-mail: mandeepbajaj{at}hotmail.com.

Splanchnic Glucose Uptake (SGU) accounts for the disposal of approximately 1/3 of an oral glucose load. To investigate the effect of an elevated plasma free fatty acid concentration on SGU, we measured SGU in 9 healthy non-diabetic subjects (age 44±4 y, BMI=27.4±1.2kg/m2,FPG=5.2±0.1mmol/L)during an Intralipid/heparin (LIP) infusion and during a saline (SAL)infusion.SGU was estimated by the ORAL GLUCOSE LOAD(OGL)-INSULIN CLAMP method: subjects received a 7h euglycemic 100 mU/m2per minute insulin clamp and a 75g oral glucose load(OGL)was ingested 3h after starting the insulin clamp.After glucose ingestion, the steady state glucose infusion rate(GIR)during the insulin clamp was decreased appropriately to maintain euglycemia. SGU was calculated by subtracting the integrated decrease in GIR during the 4h period after glucose ingestion from the ingested glucose load. 3-[ 3H] glucose was infused during the initial 3h of the insulin clamp prior to glucose ingestion to determine the rate of endogenous glucose production (EGP) and glucose disappearance rates (Rd). The plasma FFA concentration was higher during the LIP vs. SAL infusion study (2.40±0.3 vs. 0.14±0.01mM, p<0.001). During the 3h euglycemic insulin clamp prior to glucose ingestion, the rate of glucose disposal (Rd) was decreased (8.8±0.5 vs. 7.6±0.5 mg/kg-min, p<0.01) and suppression of EGP was impaired(0.2±0.04 vs. 0.07±0.03 mg/kg-min,p<0.01). During the 4h period after glucose ingestion, SGU was significantly increased during the LIP vs. SAL infusion study (30±2% vs. 20±%,p<0.005).In conclusion, an elevation in plasma FFA concentration impairs whole body glucose disposal and insulin-mediated suppression of EGP in healthy subjects, but augments SGU.These results provide evidence for "cross talk" (that is independent of hyperglycemia) between peripheral tissues (muscle) and liver in the maintainance of normal glucose homeostasis.




This article has been cited by other articles:


Home page
Diabetes CareHome page
P. Iozzo, K. Hallsten, V. Oikonen, K. A. Virtanen, R. Parkkola, J. Kemppainen, O. Solin, F. Lonnqvist, E. Ferrannini, J. Knuuti, et al.
Effects of Metformin and Rosiglitazone Monotherapy on Insulin-Mediated Hepatic Glucose Uptake and Their Relation to Visceral Fat in Type 2 Diabetes
Diabetes Care, July 1, 2003; 26(7): 2069 - 2074.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
Y. L. Muller, C. Bogardus, B. A. Beamer, A. R. Shuldiner, and L. J. Baier
A Functional Variant in the Peroxisome Proliferator-Activated Receptor {gamma}2 Promoter Is Associated With Predictors of Obesity and Type 2 Diabetes in Pima Indians
Diabetes, July 1, 2003; 52(7): 1864 - 1871.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2002 by the American Physiological Society.